| Name | Title | Contact Details |
|---|---|---|
Bryan Garabrandt |
Chief Technologist | Profile |
Dufort et Lavigne is a Montreal-Est, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find Fight and Follow® serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New York, New Jersey, Canada and Sweden.
Form Health helps people lose weight in a medically supervised environment.
Berkeley Premium Nutraceuticals is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Echo, a HealthStream Company, is a combination of two industry leading software development companies, HealthLine Systems and Sy.Med Development. Echo develops and supports a comprehensive solution set for healthcare provider credentialing, privileging, enrollment, referral, onboarding, and analytics. Echo is supported by an industry leading development and client services staff with significant combined experience in the healthcare industry.